Expanding role of mineralocorticoid receptor antagonists in the treatment of heart failure.

about

Efficacy and safety of mineralocorticoid receptor antagonists for patients with heart failure and diabetes mellitus: a systematic review and meta-analysis Interfering with mineralocorticoid receptor activation: the past, present, and future

P2860

Q26773030-5F83D142-44D4-4D17-BDD2-590193F0AF1F Q34019947-7F692A93-8B8D-41C6-9456-2842625B0500

P2860

Expanding role of mineralocorticoid receptor antagonists in the treatment of heart failure.

Item

http://www.wikidata.org/entity/Q38040730

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Expanding role of mineralocort ...... he treatment of heart failure.

@en

type

Item

label

Expanding role of mineralocort ...... he treatment of heart failure.

@en

prefLabel

Expanding role of mineralocort ...... he treatment of heart failure.

@en

P1476

Expanding role of mineralocort ...... he treatment of heart failure.

@en

P2093

Alidz Talatinian

http://www.w3.org/2001/XMLSchema#string

J Thomas Heywood

http://www.w3.org/2001/XMLSchema#string

Sheryl L Chow

http://www.w3.org/2001/XMLSchema#string

P2860

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: de

A comparison of the aldosterone-blocking agents eplerenone and spironolactone

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Mineralocorticoid receptor antagonists: The evolution of utility and pharmacology

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.

HFSA 2010 Comprehensive Heart Failure Practice Guideline.

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.

P304

827-837

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/J.1875-9114.2012.01104.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22949142

http://www.w3.org/2001/XMLSchema#string

Expanding role of mineralocorticoid receptor antagonists in the treatment of heart failure.

about

P2860

P2860

Expanding role of mineralocorticoid receptor antagonists in the treatment of heart failure.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698